Correspondence 0001193125-26-221571 from Jade Biosciences, Inc. (JBIO)
Jade Biosciences, Inc.
Date: May 13, 2026 · CIK: 0001798749 · Accession: 0001193125-26-221571
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295665
Letter
Re: Jade Biosciences, Inc. Registration Statement on Form S-3 File No. 333-295665 To the addressee set forth above: Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Jade Biosciences, Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on May 15, 2026, or as soon as practicable thereafter. If you have any questions or require additional information, please contact Anthony Gostanian of Latham & Watkins LLP at (858) 523-3969. Thank you for your assistance and cooperation in this matter.
Jade Biosciences, Inc. 221 Crescent St., Building 23, Suite 105 Waltham, MA 02453 May 13, 2026 VIA EDGAR Daniel Crawford Office of Life Sciences Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549
Sincerely,
JADE BIOSCIENCES, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Jade Biosciences, Inc. 221 Crescent St., Building 23, Suite 105 Waltham, MA 02453 May 13, 2026 VIA EDGAR Daniel Crawford Office of Life Sciences Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Jade Biosciences, Inc. Registration Statement on Form S-3 File No. 333-295665 To the addressee set forth above: Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Jade Biosciences, Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on May 15, 2026, or as soon as practicable thereafter. If you have any questions or require additional information, please contact Anthony Gostanian of Latham & Watkins LLP at (858) 523-3969. Thank you for your assistance and cooperation in this matter. Sincerely, JADE BIOSCIENCES, INC. By: /s/ Elizabeth Balta Elizabeth Balta Chief Legal Officer and Corporate Secretary cc: Tom Frohlich, Jade Biosciences, Inc. Bradford Dahms, Jade Biosciences, Inc. Cheston Larson, Latham & Watkins LLP Matthew T. Bush, Latham & Watkins LLP Anthony Gostanian, Latham & Watkins LLP